Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: NEOMATRIX THERAPEUTICS INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-09-09 to 2025-09-08
Current total value of award: $2923902
Description: CNP8 DELIVERED TOPICALLY IN A TYROSINE-DERIVED FIBER MAT TO REDUCE BURN INJURY PROGRESSION, SPEED WOUND CLOSURE, AND MITIGATE SCARRING